(ECC) Eagle Point Credit - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2698081013
Stock: Fixed Income, Loans, Debt, Investments
Total Rating 19
Risk 79
Buy Signal -1.17
| Risk 5d forecast | |
|---|---|
| Volatility | 59.3% |
| Relative Tail Risk | -4.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.36 |
| Alpha | -59.07 |
| Character TTM | |
|---|---|
| Beta | 0.736 |
| Beta Downside | 0.691 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.61% |
| CAGR/Max DD | -0.26 |
EPS (Earnings per Share)
Revenue
Description: ECC Eagle Point Credit March 05, 2026
Eagle Point Credit Company Inc. (ECC) is a US-based closed-end fund, established in 2014.
It invests in the US fixed income market, specifically focusing on equity and junior debt tranches of collateralized loan obligations (CLOs).
CLOs are securitized portfolios of primarily below investment-grade US senior secured loans, providing exposure to corporate debt.
This investment strategy targets higher yields but also carries increased risk due to the subordinate nature of the tranches and the credit quality of the underlying loans.
For more detailed analysis, consider exploring ValueRays comprehensive data on ECC.
Headlines to watch out for
- CLO equity tranche performance dictates fund returns
- Interest rate fluctuations impact CLO valuations
- Credit quality of underlying loans affects income
- Regulatory changes for CLOs create investment risk
- Demand for floating-rate debt influences CLO issuance
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -120.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.78 > 1.0 |
| NWC/Revenue: 47.29% < 20% (prev -33.51%; Δ 80.80% < -1%) |
| CFO/TA 0.05 > 3% & CFO 71.1m > Net Income -120.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (131.8m) vs 12m ago 17.86% < -2% |
| Gross Margin: 81.02% > 18% (prev 0.11%; Δ 8.09k% > 0.5%) |
| Asset Turnover: 11.19% > 50% (prev 3.40%; Δ 7.79% > 0%) |
| Interest Coverage Ratio: 1.78 > 6 (EBITDA TTM -35.6m / Interest Expense TTM 23.9m) |
Altman Z'' 1.27
| A: 0.06 (Total Current Assets 96.7m - Total Current Liabilities 20.0m) / Total Assets 1.39b |
| B: -0.37 (Retained Earnings -515.5m / Total Assets 1.39b) |
| C: 0.03 (EBIT TTM 42.6m / Avg Total Assets 1.45b) |
| D: 1.83 (Book Value of Equity 750.9m / Total Liabilities 411.0m) |
| Altman-Z'' Score: 1.27 = BB |
Beneish M
| DSRI: 0.30 (Receivables 49.3m/51.9m, Revenue 162.2m/51.1m) |
| GMI: 0.13 (GM 81.02% / 10.51%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 3.17 (Revenue 162.2m / 51.1m) |
| TATA: -0.14 (NI -120.8m - CFO 71.1m) / TA 1.39b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of ECC shares?
As of March 18, 2026, the stock is trading at USD 3.61 with a total of 1,147,746 shares traded.
Over the past week, the price has changed by -10.77%, over one month by -10.55%, over three months by -29.99% and over the past year by -41.48%.
Over the past week, the price has changed by -10.77%, over one month by -10.55%, over three months by -29.99% and over the past year by -41.48%.
Is ECC a buy, sell or hold?
Eagle Point Credit has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy ECC.
- StrongBuy: 4
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ECC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.4 | 159.8% |
| Analysts Target Price | 9.4 | 159.8% |
ECC Fundamental Data Overview March 17, 2026
P/E Forward = 4.4783
P/S = 2.3004
P/B = 0.6249
Revenue TTM = 162.2m USD
EBIT TTM = 42.6m USD
EBITDA TTM = -35.6m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 388.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 341.3m USD (from netDebt column, last quarter)
Enterprise Value = 810.6m USD (469.2m + Debt 388.7m - CCE 47.4m)
Interest Coverage Ratio = 1.78 (Ebit TTM 42.6m / Interest Expense TTM 23.9m)
EV/FCF = 11.40x (Enterprise Value 810.6m / FCF TTM 71.1m)
FCF Yield = 8.77% (FCF TTM 71.1m / Enterprise Value 810.6m)
FCF Margin = 43.82% (FCF TTM 71.1m / Revenue TTM 162.2m)
Net Margin = -74.48% (Net Income TTM -120.8m / Revenue TTM 162.2m)
Gross Margin = 81.02% ((Revenue TTM 162.2m - Cost of Revenue TTM 30.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.58 (Enterprise Value 810.6m / Total Assets 1.39b)
Interest Expense / Debt = 1.77% (Interest Expense 6.88m / Debt 388.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = 33.7m (EBIT 42.6m * (1 - 21.00%))
Current Ratio = 4.84 (Total Current Assets 96.7m / Total Current Liabilities 20.0m)
Debt / Equity = 0.40 (Debt 388.7m / totalStockholderEquity, last quarter 983.9m)
Debt / EBITDA = -9.59 (negative EBITDA) (Net Debt 341.3m / EBITDA -35.6m)
Debt / FCF = 4.80 (Net Debt 341.3m / FCF TTM 71.1m)
Total Stockholder Equity = 1.06b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.33% (Net Income -120.8m / Total Assets 1.39b)
RoE = -11.43% (Net Income TTM -120.8m / Total Stockholder Equity 1.06b)
RoCE = 3.10% (EBIT 42.6m / Capital Employed (Total Assets 1.39b - Current Liab 20.0m))
RoIC = 2.81% (NOPAT 33.7m / Invested Capital 1.20b)
WACC = 5.35% (E(469.2m)/V(858.0m) * Re(8.63%) + D(388.7m)/V(858.0m) * Rd(1.77%) * (1-Tc(0.21)))
Discount Rate = 8.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 30.88%
[DCF] Terminal Value 88.43% ; FCFF base≈84.1m ; Y1≈103.7m ; Y5≈176.6m
[DCF] Fair Price = 36.43 (EV 5.14b - Net Debt 341.3m = Equity 4.80b / Shares 131.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -58.43 | EPS CAGR: -8.14% | SUE: 0.20 | # QB: 0
Revenue Correlation: -26.10 | Revenue CAGR: -10.49% | SUE: -1.75 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.23 | Chg7d=-0.010 | Chg30d=-0.010 | Revisions Net=-2 | Analysts=4
EPS current Year (2026-12-31): EPS=0.89 | Chg7d=-0.046 | Chg30d=-0.046 | Revisions Net=-2 | Growth EPS=-9.5% | Growth Revenue=-3.9%
EPS next Year (2027-12-31): EPS=0.94 | Chg7d=-0.065 | Chg30d=-0.065 | Revisions Net=+0 | Growth EPS=+5.5% | Growth Revenue=+8.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
P/S = 2.3004
P/B = 0.6249
Revenue TTM = 162.2m USD
EBIT TTM = 42.6m USD
EBITDA TTM = -35.6m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 388.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 341.3m USD (from netDebt column, last quarter)
Enterprise Value = 810.6m USD (469.2m + Debt 388.7m - CCE 47.4m)
Interest Coverage Ratio = 1.78 (Ebit TTM 42.6m / Interest Expense TTM 23.9m)
EV/FCF = 11.40x (Enterprise Value 810.6m / FCF TTM 71.1m)
FCF Yield = 8.77% (FCF TTM 71.1m / Enterprise Value 810.6m)
FCF Margin = 43.82% (FCF TTM 71.1m / Revenue TTM 162.2m)
Net Margin = -74.48% (Net Income TTM -120.8m / Revenue TTM 162.2m)
Gross Margin = 81.02% ((Revenue TTM 162.2m - Cost of Revenue TTM 30.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.58 (Enterprise Value 810.6m / Total Assets 1.39b)
Interest Expense / Debt = 1.77% (Interest Expense 6.88m / Debt 388.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = 33.7m (EBIT 42.6m * (1 - 21.00%))
Current Ratio = 4.84 (Total Current Assets 96.7m / Total Current Liabilities 20.0m)
Debt / Equity = 0.40 (Debt 388.7m / totalStockholderEquity, last quarter 983.9m)
Debt / EBITDA = -9.59 (negative EBITDA) (Net Debt 341.3m / EBITDA -35.6m)
Debt / FCF = 4.80 (Net Debt 341.3m / FCF TTM 71.1m)
Total Stockholder Equity = 1.06b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.33% (Net Income -120.8m / Total Assets 1.39b)
RoE = -11.43% (Net Income TTM -120.8m / Total Stockholder Equity 1.06b)
RoCE = 3.10% (EBIT 42.6m / Capital Employed (Total Assets 1.39b - Current Liab 20.0m))
RoIC = 2.81% (NOPAT 33.7m / Invested Capital 1.20b)
WACC = 5.35% (E(469.2m)/V(858.0m) * Re(8.63%) + D(388.7m)/V(858.0m) * Rd(1.77%) * (1-Tc(0.21)))
Discount Rate = 8.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 30.88%
[DCF] Terminal Value 88.43% ; FCFF base≈84.1m ; Y1≈103.7m ; Y5≈176.6m
[DCF] Fair Price = 36.43 (EV 5.14b - Net Debt 341.3m = Equity 4.80b / Shares 131.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -58.43 | EPS CAGR: -8.14% | SUE: 0.20 | # QB: 0
Revenue Correlation: -26.10 | Revenue CAGR: -10.49% | SUE: -1.75 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.23 | Chg7d=-0.010 | Chg30d=-0.010 | Revisions Net=-2 | Analysts=4
EPS current Year (2026-12-31): EPS=0.89 | Chg7d=-0.046 | Chg30d=-0.046 | Revisions Net=-2 | Growth EPS=-9.5% | Growth Revenue=-3.9%
EPS next Year (2027-12-31): EPS=0.94 | Chg7d=-0.065 | Chg30d=-0.065 | Revisions Net=+0 | Growth EPS=+5.5% | Growth Revenue=+8.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)